Anifrolumab Tied to Lower Hospitalization, Infection Risk in Lupus

TUESDAY, Sept. 15, 2026-- Anifrolumab is associated with a lower risk for infections requiring antibiotics and for hospitalizations among patients with hydroxychloroquine (HCQ)-refractory chronic cutaneous lupus erythematosus (CCLE) and systemic...